Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal indomethacin and intravenous hydration for prevention of post-ERCP pancreatitis
IRCT2014082418915N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of indomethacin in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) (2 arms), sponsored by Mashhad University of Medical Sciences. Started May 2013; status: completed.
02
Drugs
indomethacin
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on IRCT2014082418915N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014082418915N1.